期刊文献+

含CpG基序的寡聚脱氧核苷酸佐剂对乙型肝炎疫苗免疫效果的影响

Effect of adjuvent CpG Oligodeoxy ribonucleotide on the immune response induced by hepetitis B vaccines
下载PDF
导出
摘要 为提高乙型肝炎疫苗的免疫原性和机体对疫苗的免疫反应性,开发新型疫苗佐剂已成为国内外学者研究的热点。大量的研究表明,CpC基序的寡聚脱氧核苷酸佐剂(CpC ODN)是很有前途的细胞免疫和体液免疫增强剂,与铝佐剂有协同作用,并可克服铝佐剂对细胞免疫的抑制;CpC ODN作为佐剂稳定性较好,对人体安全,尤其是与Al(OH)_3联合作为HBsAg疫苗佐剂时,双剂接种就可以获得很理想的免疫效果,并且价廉,有利于提高发展中国家的乙型肝炎疫苗接种率。本文着重对含有一个或数个非甲基化CpC ODN的研究进展作了综述。
出处 《国外医学(流行病学.传染病学分册)》 2004年第2期86-90,共5页 Epidemiology Lemology Foreign Medical Sciences
  • 相关文献

参考文献25

  • 1Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA.J Immunol, 1996,157(5):2116-2122.
  • 2Krieg AM, Ae-Kyung Yi, Matson S, et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 1995,374: 546-549.
  • 3Davis -HL, Weerantna R, Waldschmidt TJ,et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J Immunol, 1998,160(2):870-876.
  • 4许洪林,王四清,王世峰,郭斐,陆柔剑,阮力.利用小鼠模型评价含有5'-GTCGTT-3'特征序列的人CpG寡脱氧核苷酸的免疫刺激活性[J].病毒学报,2001,17(1):43-47. 被引量:12
  • 5Gursel M, Tunca S, Ozkan M, et al. Immunoadjuvant action of plasmid DNA in liposomes. Vaccine, 1999,17(11-12): 1376-1383.
  • 6Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells. J Immunol, 2000, 164(2):944-952.
  • 7Weeratna R, Comanita L, Davis -HL. CpG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice. Immunol Cell Biol,2003,81 (1): 59-62.
  • 8王四清,田淑芳,许洪林,郭斐,王文,陈红,王秀平,王世峰,阮力.CpG对乙型肝炎基因重组(CHO细胞)疫苗免疫效果的影响[J].病毒学报,2002,18(2):108-112. 被引量:8
  • 9Weeratua RD, Brazolot Millan CL, Mccluskie MJ,et al. CpG ODN can re-direct the Th biax of established Th2 immune responses in adult and young mice. FEMS Immunol Med Microbiol, 2001,32( 1 ) :65-71.
  • 10Davis HL, Weeratna R, Waldschmidt TJ, et al. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine,2000,18(18):1920-1924.

二级参考文献24

  • 1[1]Fujihashi K, Koga T, McGhee J. Mucosal vaccination and immune responses in the elderly. Vaccine ,2000; 18(16):1675~80
  • 2[2]Evans TG, Judd ME, Dowell T et al. The use of oral dehydroepiandrosterone sulfate as an adjuvant in tetanus and influenza vaccination of the elderly. Vaccine,1996; 14(16):1531~7
  • 3[3]Higgins DA, Carlson JR,van Nest D. Mf59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. Vaccine,1996; 14(6):478~84
  • 4[4]Newman MJ, Todd CW, Lee EM et al. Increasing the immunogenicity of a trivalent influenza virus vaccine with adjuvant-active nonionic block copolymers for potential use in the elderly. Mech Ageing Dev,1997;93(1~3):189~203
  • 5[5]Sambhara S, Woods S, Arpino R et al. Influenza (H1N1)-ISCOMs enhance immune reponses and protection in aged mice. Mech Ageing Dev,1997;96(1~3):157~69
  • 6[6]Davis HL, Weeranta R, Waldschmidt TJ et al. CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. Journal of Immunology, 1998; 160(7):870~6
  • 7[7]Krieg AM, Schorr J, Davis HL et al. The role of CpG deoxynucleotides in DNA vaccine, Trend Microbiol,1998; 6(1):23~7
  • 8李文波,新消化病学杂志,1999年,7卷,3期,188页
  • 9Krieg A M,Nature,1995年,6522期,546页
  • 10Wang B,Proc Nat Acad Sci SUA,1993年,90卷,7期,4156页

共引文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部